|Thursday, July 20, 12 to 1 p.m. ET|
We'll talk about why we need to test these drugs in Parkinson's, how they're identified and go through some in the pipeline.
Q&A with participants will follow the discussion.
Thank you to our Parkinson's Disease Education Consortium members. While our generous sponsors make our educational offerings possible, their support does not influence MJFF's content, perspective or panelist selection.
sábado, 8 de julio de 2017
Drug Repurposing: Testing a Drug Approved for One Disease for its Efficacy in Another
Publicado por salud equitativa en 10:35
Suscribirse a: Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario